Form 4 for DVA DaVita
Accepted 2024-11-27 00:00:00 ET · period of report 2024-11-27 · accession 0000927066-24-000202 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-27 | 2024-11-27 | DVA | Waters Kathleen Alyce | Chief Legal, Pub. Affairs Off | D - Sale to Iss | $167.96 | -5,239 | 92.5K | -5% | -$879.9K |
| D | 2024-11-27 | 2024-11-27 | DVA | Waters Kathleen Alyce | Chief Legal, Pub. Affairs Off | F - Tax | $167.96 | -1,439 | 91.0K | -2% | -$241.7K |
| D | 2024-11-27 | 2024-11-27 | DVA | Waters Kathleen Alyce | Chief Legal, Pub. Affairs Off | M - OptEx | $108.93 | +8,078 | 97.7K | +9% | +$879.9K |
| D | 2024-11-27 | 2024-11-27 | DVA | Waters Kathleen Alyce | Chief Legal, Pub. Affairs Off | M - OptEx | $0.00 | -8,078 | 8,079 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-27 | D | D | 5,239 | $167.96 | 92,467 | D | — | — | (F1) Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. |
| 2 | Common | Common Stock | 2024-11-27 | F | D | 1,439 | $167.96 | 91,028 | D | — | — | (F2) Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. |
| 3 | Common | Common Stock | 2024-11-27 | M | A | 8,078 | $108.93 | 97,706 | D | — | — | |
| 4 | Derivative | Stock Appreciation Rights | 2024-11-27 | M | D | 8,078 | $0.00 | 8,079 | D | $108.93 · — to 2026-03-15 | 8,078 Common Stock | (F3) The Stock Appreciation Rights were granted on March 15, 2021, in which 50% vested on March 15, 2024 and the remaining 50% will vest on March 15, 2025, subject to the terms and conditions of the applicable award agreement. |